Memorial Sloan Kettering Cancer Center
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1884-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.mskcc.org
Reflectance Confocal Microscopy of Oral Cancers in Vivo: a Preliminary Trial Comparing Intra-oral Imaging With Pathology
- Conditions
- Head and Neck CancerSquamous Cell Carcinoma (SCC) of the Oral Cavity
- Interventions
- Device: Reflectance Confocal Microscopy
- First Posted Date
- 2015-07-23
- Last Posted Date
- 2025-03-12
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 140
- Registration Number
- NCT02507141
- Locations
- 🇺🇸
Memorial Sloan Kettering Basking Ridge (consent only), Basking Ridge, New Jersey, United States
🇺🇸Memorial Sloan Kettering Monmouth (consent only), Middletown, New Jersey, United States
🇺🇸Memorial Sloan Kettering Cancer Center, New York, New York, United States
Humanized Monoclonal Antibody 3F8 (Hu3F8) With Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) in the Treatment of Recurrent Osteosarcoma
- Conditions
- Recurrent Osteosarcoma
- Interventions
- Biological: humanized anti-GD2 antibody
- First Posted Date
- 2015-07-20
- Last Posted Date
- 2024-10-29
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 46
- Registration Number
- NCT02502786
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸Children's Hospital of Los Angeles (Data Collection Only), Los Angeles, California, United States
🇺🇸MD ANDERSON CANCER CENTER (Data Collection Only), Houston, Texas, United States
Caregiver Burden Within the Ambulatory Extended Recovery (AXR) Patient Population
- Conditions
- Caregiver Burden
- Interventions
- Behavioral: Caregiver Reaction Assessment (CRA)Behavioral: The Caregiver Quality of Life - Cancer (CQOLC)
- First Posted Date
- 2015-07-17
- Last Posted Date
- 2018-08-14
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 47
- Registration Number
- NCT02501785
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Cyclophosphamide Followed by Intravenous and Intraperitoneal Infusion of Autologous T Cells Genetically Engineered to Secrete IL-12 and to Target the MUC16ecto Antigen in Patients With Recurrent MUC16ecto+ Solid Tumors
- Conditions
- Solid Tumors
- Interventions
- Procedure: Production of Genetically-modified T cellsDevice: IP Catheter InsertionGenetic: Infusion of 4H11-28z/fIL-12/EGFRt+ Genetically-modified T cells
- First Posted Date
- 2015-07-15
- Last Posted Date
- 2024-07-31
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 18
- Registration Number
- NCT02498912
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Study to Evaluate the Efficacy and Safety of Nintedanib (BIBF 1120) + Prednisone Taper in Patients With Radiation Pneumonitis
- Conditions
- Lung CancerLung Metastases
- Interventions
- First Posted Date
- 2015-07-14
- Last Posted Date
- 2025-04-16
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 34
- Registration Number
- NCT02496585
- Locations
- 🇺🇸
Memorial Sloan Kettering Nassau, Uniondale, New York, United States
🇺🇸Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States
Adding Ruxolitinib to a Combination of Dasatinib Plus Dexamethasone in Remission Induction Therapy in Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Patients Aged 40 Years or Older
- Conditions
- Acute Lymphoblastic Leukemia
- Interventions
- First Posted Date
- 2015-07-10
- Last Posted Date
- 2024-07-29
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 12
- Registration Number
- NCT02494882
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Dose-Response of Aerobic Training in Women at High-Risk for Development of Breast Cancer
- Conditions
- High Risk for Developing Breast Cancer
- Interventions
- Behavioral: Nonlinear Aerobic TrainingOther: Height, Weight, BMI measureOther: Blood drawOther: Cardiopulmonary exercise test
- First Posted Date
- 2015-07-10
- Last Posted Date
- 2024-08-29
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 75
- Registration Number
- NCT02494869
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Immunotherapy for the Treatment of Breast Cancer Related Upper Extremity Lymphedema (BCRL)
- First Posted Date
- 2015-07-10
- Last Posted Date
- 2018-11-08
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 9
- Registration Number
- NCT02494206
- Locations
- 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
Mirena® IUD's Effect on Fallopian Tube Fimbriae and Ovarian Cortical Inclusion Cyst Cell Proliferation
- Conditions
- Epithelial Ovarian Cancer
- Interventions
- Device: Mirena® intra-uterine device (IUD)
- First Posted Date
- 2015-06-22
- Last Posted Date
- 2023-10-16
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 7
- Registration Number
- NCT02477202
- Locations
- 🇺🇸
Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
🇺🇸Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States
🇺🇸Memorial Sloan Kettering Commack, Commack, New York, United States
Detection of Acid Sphingomyelinase/Ceramide Pathway Activation in Radiotherapy Patients Using Intravoxel Incoherent Motion (IVIM) Diffusion-weighted Magnetic Resonance Imaging and Serum Biomarkers
- Conditions
- Metastatic Disease to BoneMetastatic Disease to Soft Tissue
- Interventions
- Device: MRI with IVIM DW-MRIOther: Blood draw
- First Posted Date
- 2015-06-08
- Last Posted Date
- 2016-09-21
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Registration Number
- NCT02465723
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States